The estimated Net Worth of Josiah Hornblower is at least 20.1 百万$ dollars as of 15 July 2021. Mr Hornblower owns over 34 units of Shattuck Labs stock worth over 11,065,825$ and over the last 4 years he sold STTK stock worth over 8,638,400$. In addition, he makes 384,368$ as Co-Founder & Exec. Chairman at Shattuck Labs.
Mr has made over 16 trades of the Shattuck Labs stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 34 units of STTK stock worth 773$ on 15 July 2021.
The largest trade he's ever made was exercising 188,375 units of Shattuck Labs stock on 23 June 2021 worth over 879,711$. On average, Mr trades about 27,984 units every 4 days since 2020. As of 15 July 2021 he still owns at least 2,966,709 units of Shattuck Labs stock.
You can see the complete history of Mr Hornblower stock trades at the bottom of the page.
Josiah C. Hornblower is the Co-Founder & Exec. Chairman at Shattuck Labs.
As the Co-Founder & Exec. Chairman of Shattuck Labs, the total compensation of Mr Hornblower at Shattuck Labs is 384,368$. There are 5 executives at Shattuck Labs getting paid more, with Dr. Arundathy Nirmalini Pandite M.B.A., M.D. having the highest compensation of 583,002$.
Mr Hornblower is 44, he's been the Co-Founder & Exec. Chairman of Shattuck Labs since . There are 3 older and 4 younger executives at Shattuck Labs. The oldest executive at Shattuck Labs, Inc. is Dr. Arundathy Nirmalini Pandite M.B.A., M.D., 62, who is the Chief Medical Officer.
Josiah's mailing address filed with the SEC is C/O SHATTUCK LABS, INC., 500 W. 5TH STREET, SUITE 1200, AUSTIN, TX, 78701.
Over the last 4 years, insiders at Shattuck Labs have traded over 14,634,250$ worth of Shattuck Labs stock and bought 3,526,605 units worth 60,008,520$ . The most active insiders traders include Group, Llc Green Jeremy Red...、Clay B Siegall、Josiah Hornblower. On average, Shattuck Labs executives and independent directors trade stock every 25 days with the average trade being worth of 300,381$. The most recent stock trade was executed by Tyler Brous on 27 June 2024, trading 8,416 units of STTK stock currently worth 32,738$.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also holds a collaboration agreement with Takeda Pharmaceuticals to develop SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Shattuck Labs executives and other stock owners filed with the SEC include: